Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.41 USD | +6.43% | +15.12% | +13.33% |
03-13 | Top Premarket Decliners | MT |
03-12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.33% | 419M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- Insider Sell: Iteos Therapeutics